Stock Scorecard



Stock Summary for Lantheus Holdings Inc (LNTH) - $78.95 as of 5/13/2025 8:47:06 PM EST

Total Score

12 out of 30

Safety Score

62 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for LNTH

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for LNTH

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for LNTH

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for LNTH

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for LNTH (62 out of 100)

Stock Price Rating (Max of 10) 9
Historical Stock Price Rating (Max of 10) 7
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 6
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 5
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 7
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for LNTH

Perspective Therapeutics Provides Recent Business Highlights and Reports 1Q 2025 Results 5/12/2025 8:36:00 PM
Should Invesco S&P MidCap 400 GARP ETF ( GRPM ) Be on Your Investing Radar? 5/8/2025 10:20:00 AM
Sarepta Therapeutics, Mercury Systems, Arista Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Arista Networks ( NYSE:ANET ) , Apellis Pharmaceuticals ( NASDAQ:APLS ) 5/7/2025 12:10:00 PM
Lantheus Announces Sale of SPECT Business to SHINE Technologies - Lantheus Holdings ( NASDAQ:LNTH ) 5/6/2025 8:01:00 PM
Is Invesco S&P MidCap 400 GARP ETF ( GRPM ) a Strong ETF Right Now? 5/6/2025 10:20:00 AM
Contrast Media Market is expected to generate a revenue of USD 6.8 Billion by 2031, Globally, at 2.59% CAGR: Verified Market Research® 4/25/2025 2:00:00 PM
NurExone Appoints Biotech Industry Leader - Jacob Licht to Lead U.S. Operations and Exo-Top Manufacturing Expansion and Completes Continuance into Ontario - NurExone Biologic ( OTC:NRXBF ) 4/22/2025 8:05:00 PM
Lantheus Completes Acquisition of Evergreen Theragnostics - Lantheus Holdings ( NASDAQ:LNTH ) 4/1/2025 1:00:00 PM
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2024 Results 3/26/2025 8:10:00 PM
Here's Why You Should Hold GEHC Stock in Your Portfolio for Now 3/24/2025 2:12:00 PM

Financial Details for LNTH

Company Overview

Ticker LNTH
Company Name Lantheus Holdings Inc
Country USA
Description Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.
Sector Name LIFE SCIENCES
Industry Name IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Most Recent Quarter 3/31/2025
Next Earnings Date N/A

Stock Price History

Last Day Price 78.95
Price 4 Years Ago 28.89
Last Day Price Updated 5/13/2025 8:47:06 PM EST
Last Day Volume 1,240,523
Average Daily Volume 1,174,758
52-Week High 126.89
52-Week Low 75.00
Last Price to 52 Week Low 5.27%

Valuation Measures

Trailing PE 23.29
Industry PE 34.41
Sector PE 49.22
5-Year Average PE 31.59
Free Cash Flow Ratio 5.82
Industry Free Cash Flow Ratio 127.60
Sector Free Cash Flow Ratio 31.82
Current Ratio Most Recent Quarter 5.74
Total Cash Per Share 13.57
Book Value Per Share Most Recent Quarter 16.84
Price to Book Ratio 5.08
Industry Price to Book Ratio 16.20
Sector Price to Book Ratio 30.58
Price to Sales Ratio Twelve Trailing Months 3.68
Industry Price to Sales Ratio Twelve Trailing Months 6.87
Sector Price to Sales Ratio Twelve Trailing Months 25.54
Analyst Buy Ratings 9
Analyst Strong Buy Ratings 3

Share Statistics

Total Shares Outstanding 69,186,000
Market Capitalization 5,462,234,700
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY -45.50%
Annual Earnings Growth -4.35%
Reported EPS 12 Trailing Months 3.51
Reported EPS Past Year 1.53
Reported EPS Prior Year 6.78
Net Income Twelve Trailing Months 254,321,000
Net Income Past Year 312,442,000
Net Income Prior Year 326,661,000
Quarterly Revenue Growth YOY 0.80%
5-Year Revenue Growth 34.59%
Operating Margin Twelve Trailing Months 27.40%

Balance Sheet

Total Cash Most Recent Quarter 938,533,000
Total Cash Past Year 912,814,000
Total Cash Prior Year 713,656,000
Net Cash Position Most Recent Quarter 372,435,000
Net Cash Position Past Year 347,535,000
Long Term Debt Past Year 565,279,000
Long Term Debt Prior Year 561,670,000
Total Debt Most Recent Quarter 566,098,000
Equity to Debt Ratio Past Year 0.66
Equity to Debt Ratio Most Recent Quarter 0.67
Total Stockholder Equity Past Year 1,088,011,000
Total Stockholder Equity Prior Year 815,892,000
Total Stockholder Equity Most Recent Quarter 1,164,194,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 473,005,000
Free Cash Flow Per Share Twelve Trailing Months 6.84
Free Cash Flow Past Year 493,125,000
Free Cash Flow Prior Year 258,705,000

Options

Put/Call Ratio 1.07
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -2.85
MACD Signal -0.01
20-Day Bollinger Lower Band 76.56
20-Day Bollinger Middle Band 93.83
20-Day Bollinger Upper Band 111.10
Beta 0.23
RSI 32.64
50-Day SMA 96.30
150-Day SMA 78.75
200-Day SMA 68.69

System

Modified 5/13/2025 4:23:15 AM EST